Revolutionizing Tear Biomarker Remote Sensing
LacriStat.AI: Innovative Solutions for Dry Eye Care and Women's Health
Discover the future of eye and women’s health with LacriStat.AI, where cutting-edge technology meets compassionate care.
Pioneering Eye and Women's Health Innovation
LacriStat.AI is at the forefront of transforming the diagnosis and treatment of dry eye and infertility. Our LacriStat™ and LacriSync™ products are designed to help patients with dry eye and infertility, respectively. Our mission is to harness AI, nano-fluidics, microelectronics and other advanced technologies to develop real-time, closed-loop solutions to improve the management of these conditions. At our ophthalmic incubator, headquartered at 1190 O’Brien Drive in Menlo Park California, our goal is to empower our team of researchers and engineers to innovate and collaborate to improve patient outcomes. Under the leadership of Dimitri Azar, MD, MBA, we are committed to pushing the boundaries of what’s possible in ophthalmic and dry eye care.
Our journey began with a simple question: How can we make a meaningful impact on the lives of those suffering from dry eye disease and infertility? At LacriStat.AI, we believe the answer lies in continuous innovation and a relentless pursuit of excellence. Our team is comprised of engineers, scientists and ophthalmologists who are predominantly Google, Verily and Twenty/Twenty alumni. We are driven by a shared passion for discovery and a commitment to delivering tangible results to patients. By fostering a supportive environment and encouraging creative problem-solving, we aim to redefine the landscape of dry eye and women’s health and set new standards for the industry.